×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Russia Not on Track for Mass Coronavirus Vaccination by Year-End – The Bell

Yevgeny Sofiychuk / TASS

Russia will likely miss its self-imposed timeline for mass vaccination against the coronavirus because of insufficient production capacity, the business news website The Bell reported Tuesday.

Authorities have vowed to vaccinate a sizable part of Russia’s population by the end of 2020, but developers are reportedly facing issues with scalability and quality control. As a result, manufacturers expect hundreds of thousands instead of the promised tens of millions of vaccine doses by year-end.

“We can’t stabilize the vaccine, no one yet can,” The Bell quoted an unnamed executive at one of four Russian manufacturing partners of Moscow’s Gamaleya research institute as saying. The institute developed  Sputnik V, the world’s first registered coronavirus vaccine.

Batches of vaccines often don’t meet Gamaleya’s quality standards and launches of cell-growing vessels known as bioreactors are “generally unsuccessful” when scaled up, an unnamed source familiar with the process told The Bell.

“It usually takes a year to set up mass production of this scale, and here we are trying to make it within weeks,” said Anton Gopka, general partner at the biotech and healthcare investment firm ATEM Capital.

President Vladimir Putin acknowledged issues with vaccine production last week, saying “there are certain problems linked to the availability or lack of the necessary equipment.” Reuters reported around the same time that some of Moscow’s clinics have paused clinical trials of the vaccine after using up all the allocated doses.

The Russian Direct Investment Fund (RDIF), which has promised to invest $50 million into Sputnik V, told The Bell that it expects to reach the manufacture of between 7 million and 10 million vaccine doses by January at the latest.

“Bioreactor launches are going well,” RDIF said. “The main production task is to scale the process and use larger volumes of bioreactors.” 

The scientists are “working around the clock” and “get irritated” at the Russian officials’ public promise of imminent mass production of the coronavirus vaccine, The Bell cited one of its sources as saying.

Record numbers of Russians have been infected and killed by Covid-19 over the past month after a summer lull, as authorities continue to raise hopes that a mass vaccination campaign will bring the numbers down.

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more